Icecure Medical Ltd (NASDAQ: ICCM) kicked off on Monday, up 14.42% from the previous trading day, before settling in for the closing price of $0.88. Over the past 52 weeks, ICCM has traded in a range of $0.47-$1.63.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 2.44% over the past five years. While this was happening, its average annual earnings per share was recorded 26.39%. With a float of $40.31 million, this company’s outstanding shares have now reached $58.70 million.
Let’s look at the performance matrix of the company that is accounted for 72 employees.
Icecure Medical Ltd (ICCM) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Icecure Medical Ltd is 41.31%, while institutional ownership is 0.37%.
Icecure Medical Ltd (ICCM) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.08 earnings per share (EPS), higher than consensus estimate (set at -0.08) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.39% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.41% during the next five years compared to 2.44% growth over the previous five years of trading.
Icecure Medical Ltd (NASDAQ: ICCM) Trading Performance Indicators
Take a look at Icecure Medical Ltd’s (ICCM) current performance indicators. Last quarter, stock had a quick ratio of 0.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 24.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.18 in one year’s time.
Technical Analysis of Icecure Medical Ltd (ICCM)
Icecure Medical Ltd (NASDAQ: ICCM) saw its 5-day average volume 0.77 million, a positive change from its year-to-date volume of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 85.62%.
During the past 100 days, Icecure Medical Ltd’s (ICCM) raw stochastic average was set at 48.44%, which indicates a significant decrease from 93.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0651 in the past 14 days, which was lower than the 0.0687 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9671, while its 200-day Moving Average is $1.0773. Nevertheless, the first resistance level for the watch stands at $1.0462 in the near term. At $1.0823, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.1347. If the price goes on to break the first support level at $0.9577, it is likely to go to the next support level at $0.9053. The third support level lies at $0.8692 if the price breaches the second support level.
Icecure Medical Ltd (NASDAQ: ICCM) Key Stats
The company with the Market Capitalisation of 69.38 million has total of 58,697K Shares Outstanding. Its annual sales at the moment are 3,290 K in contrast with the sum of -15,320 K annual income. Company’s last quarter sales were recorded 530 K and last quarter income was 3,360 K.
